• Mechanism of Action
• Inhibits thymidylate synthase, resulting in reduced production of dTMP and reduced DNA synthesis.

Clinical Use

• • Indication
  • Certain solid organ malignancies, as guided by cancer specialists and local guidelines.
• • Adverse Effects